For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Arcturus Therapeutics, Inc.

USPTO Granted Patents = 60

CIPO Patents = 2

EPO Patents = 17

Trademarks = 4

Forward Citations = 268

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Padmanabh Chivukula (49 out of 51 patents)

Joseph E Payne (32 out of 54 patents)

Kiyoshi Tachikawa (23 out of 25 patents)

4. Priya Prakash Karmali (16 out of 30 patents)

5. Yanjie Bao (11 out of 12 patents)

6. Steven Paul Tanis (10 out of 39 patents)

7. Daiki Matsuda (9 out of 9 patents)

8. Pattraranee Limphong (6 out of 6 patents)

9. Jesper Wengel (6 out of 8 patents)

10. Jared Henry Davis (4 out of 4 patents)

11. Sean Michael Sullivan (4 out of 4 patents)

12. Amit Sagi (4 out of 4 patents)

13. Arisa Cale (3 out of 3 patents)

14. Carlos Gustavo Perez-Garcia (3 out of 4 patents)

15. Christine Esau (3 out of 4 patents)

Core Competencies:

Ionizable Cationic Lipid

RNA Delivery

Lipid Nanoparticles

Synthetic Transfer RNA

Immune Response Induction

Coronavirus Vaccine

Nucleic Acid Therapeutics

Gene Editing

Therapeutic Oligomers

Acyl-Amino-LNA

UNA Oligomers

Drug Delivery

60 patents: Sort by Forward Citations

1. RE50681 - Ionizable cationic lipid for RNA delivery (2025-12-02),

2. 12398379 - Compositions and methods for treating ornithine transcarbamylase deficiency (2025-08-26),

3. 12390524 - Compositions and methods for inducing immune responses (2025-08-19),

4. 12351834 - Compositions and methods for the treatment of ornithine transcarbamylase deficiency (2025-07-08),

5. 12290567 - Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates (2025-05-06),

6. 12286395 - Method of synthesis of an ionizable cationic lipid (2025-04-29),

7. 12220485 - Method of making lipid-encapsulated RNA nanoparticles (2025-02-11),

8. 12220455 - Coronavirus vaccine compositions and methods (2025-02-11),

9. 12178921 - Method of lyophilizing lipid nanoparticles (2024-12-31),

10. 12083224 - Lipid particles for nucleic acid delivery (2024-09-10),

11. 12077754 - Synthetic transfer RNA with extended anticodon loop (2024-09-03),

12. 12070509 - Nucleic acids and methods of treatment for cystic fibrosis (2024-08-27),

13. 11939600 - Compositions and methods for treating phenylketonuria (2024-03-26),

14. 11939363 - Translatable molecules and synthesis thereof (2024-03-26),

15. 11938227 - Lipid nanoparticles encapsulation of large RNA (2024-03-26),

Arcturus Therapeutics is a leading clinical-stage mRNA medicines company focused on the discovery, development, and commercialization of therapeutics for rare diseases and vaccines. The company utilizes its proprietary LUNAR® lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology platforms to develop a diverse range of RNA-based therapies. Arcturus' programs include treatments for liver diseases, cystic fibrosis, cardiovascular diseases, and COVID-19 vaccine development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

60 Patents

#106 in San Diego, CA

#1,363 in California

#5,788 in US

#11,665 in the World

San Diego, CA, United States of America

Arcturus Therapeutics, Inc.

Forward Citations = 268

43 inventors:

Padmanabh Chivukula (49 out of 51 patents)

Joseph E Payne (32 out of 54 patents)

Kiyoshi Tachikawa (23 out of 25 patents)

4. Priya Prakash Karmali (16 out of 30 patents)

5. Yanjie Bao (11 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…